DipCatcherDipCatcher by KAWUMS
€FRA…
£LON…
$NYC…
₿BTC24/7
Next analysis …Last run 06:05 · 31 4–5 ★ · 177 3 ★
Market
3IN.L394.50 p-0.1%8TRA.DE€34.00+1.1%A$169.90-1.8%AAF.L285.20 p-0.1%AAL.L4,047.00 p-0.3%AAPL$342.94-0.2%AAVE$149.85-1.4%ABBV$282.68-1.0%ABDN.L238.60 p0.0%ABF.L1,942.50 p+0.3%ABNB$175.46+1.0%ABT$104.06-0.8%ACN$236.93+3.2%ADA$0.2176-1.5%ADBE$247.09+0.8%ADI$394.35-0.3%ADM.L3,784.00 p+0.9%ADP$287.03-0.6%ADS.DE€158.50+0.5%AEP$124.72-1.9%AFL$118.67-1.1%AFX.DE€32.76+0.1%AIR.DE€198.92+2.2%AIXA.DE€32.89+6.2%AJG$253.01-0.7%ALGO$0.1122+1.0%ALL$246.85-0.4%ALV.DE€433.90+1.0%AMAT$413.11+0.9%AMD$538.05+1.8%AME$247.22-0.4%AMGN$424.94-1.7%AMT$183.03-1.2%AMZN$262.45+5.0%ANET$182.95+3.4%ANTO.L3,400.00 p-0.8%AON$289.74-1.0%APD$298.65-0.3%APH$80.28+1.2%APO$110.95+0.2%APP$269.12+1.1%AT1.DE€1.42+0.9%ATOM$1.76+3.9%AUTO.L546.00 p+2.3%AV.L713.00 p+0.6%AVAX$9.57-2.0%AVGO$334.59+1.8%AXP$316.41+0.9%AZN.L12,446.00 p-2.0%AZO$3,097.88-0.7%BA$191.42+0.6%BA.L1,983.50 p+2.6%BAB.L961.80 p+3.6%BAC$50.39-1.6%BARC.L432.65 p+0.1%BAS.DE€53.23+1.2%BATS.L4,457.00 p+2.1%BAYN.DE€44.46+0.1%BBY.L839.50 p+1.9%BC8.DE€34.82-0.3%BCH$277.96+0.7%BDX$190.74-0.5%BE$226.22+2.2%BEI.DE€81.82+0.3%BFSA.DE€34.000.0%BGEO.L12,580.00 p-0.4%BKG.L3,342.00 p+0.4%BKNG$162.60-0.5%BKR$55.81+0.2%BLK$1,124.60-0.9%BLND.L417.40 p-1.2%BME.L286.20 p+2.4%BMW.DE€57.06+3.5%BMY$58.83-1.5%BNB$729.26+1.0%BNR.DE€65.04+0.4%BNY$142.44-0.6%BNZL.L2,852.00 p+0.4%BOSS.DE€37.99-0.2%BP.L614.10 p+0.6%BPT.L404.20 p+1.8%BRBY.L1,102.50 p+0.0%BRK-B$532.23+0.0%BSX$45.05+1.5%BT-A.L209.70 p+1.4%BTC$81,747.10-0.3%BTRW.L311.80 p+0.6%BX$107.09+0.5%C$121.69-2.1%CAH$252.65-0.6%CARR$55.21+0.4%CAT$725.79-0.7%CB$356.27-1.0%CBK.DE€37.88+0.5%CCC.L5,100.00 p-1.2%CCEP.L8,400.00 p+1.2%CCH.L4,426.00 p-0.1%CDNS$325.86+2.0%CEG$263.19-3.0%CI$298.50-1.3%CIEN$344.20+3.4%CL$93.39-0.8%CMCSA$21.900.0%CME$293.53-0.1%CMI$522.13-1.7%CNA.L150.50 p+1.5%COF$199.83-0.9%COHR$232.02-0.4%COIN$168.45-2.7%CON.DE€69.98-0.3%COP$145.24-0.9%COR$340.00-0.3%COST$995.53+0.6%CPG.L$32.56-0.5%CRDA.L3,623.00 p+0.9%CRH$83.18-0.5%CRM$242.45+0.7%CRWD$228.10+0.3%CSCO$106.50-0.8%CSX$47.88-1.6%CTAS$212.30-0.7%CTEC.L238.00 p+0.5%CVS$92.68+0.3%CVX$224.37-0.3%CWK.L5,210.00 p0.0%D$62.21-2.1%DAL$74.63-1.0%DASH$193.53+2.3%DB1.DE€309.50+1.3%DBK.DE€29.33+0.7%DCC.L6,440.00 p+0.2%DDOG$260.36+5.4%DE$627.00-2.3%DELL$455.44+0.8%DGE.L1,790.00 p+1.9%DHER.DE€38.02+0.3%DHL.DE€58.22+0.9%DHR$224.43-2.0%DIS$109.59-0.9%DLR$173.00-1.7%DOGE$0.0794+0.1%DOT$1.14+2.1%DPLM.L7,890.00 p+1.0%DRX.L785.00 p+1.5%DTE.DE€25.89+1.2%DTG.DE€41.77+1.7%DUK$119.27-1.8%DVN$50.92+0.4%ECL$285.94-1.0%EDV.L4,196.00 p+1.8%ELV$430.23+0.5%EMG.L340.00 p+1.1%EMR$160.54-0.6%ENA$0.1884+0.1%ENR.DE€134.98+2.0%ENT.L443.70 p+1.0%EOAN.DE€17.85+1.8%EOG$157.65-0.2%EQIX$975.71-1.0%ETC$7.77+0.3%ETH$2,398.19-0.4%ETN$391.50+0.1%ETR$103.80-1.2%EVD.DE€61.75-0.2%EVK.DE€21.42+0.5%EVT.DE€2.57+1.5%EW$87.22+0.7%EXPN.L2,838.00 p-0.6%EZJ.L683.40 p0.0%F$12.18-2.0%FANG$203.12-0.4%FAST$51.020.0%FCX$69.75+0.3%FDX$293.78+0.1%FIX$1,464.07+1.7%FME.DE€39.54+0.2%FNTN.DE€22.78+0.2%FPE3.DE€45.38-0.6%FRA.DE€60.30+0.8%FRAS.L868.00 p+1.0%FRE.DE€45.08+2.8%FRES.L2,719.00 p+1.9%FTNT$171.50+1.4%G1A.DE€69.20+0.2%G24.DE€80.30+1.3%GAW.L16,990.00 p-0.6%GBF.DE€56.20+2.4%GD$341.43-0.8%GE$311.28-0.8%GEV$908.44-1.4%GFT.DE€27.20-1.4%GILD$153.07-2.0%GLEN.L583.10 p+1.6%GLW$132.74+0.6%GM$82.75-1.4%GOOG$340.16+1.0%GOOGL$344.18+1.1%GRMN$286.16+0.5%GS$875.78-0.6%GSK.L1,862.50 p-0.3%GWW$1,318.06-0.9%GXI.DE€30.44+6.1%HAG.DE€87.86+6.0%HBAR$0.0838-1.7%HBR.L293.60 p+2.2%HCA$454.88-0.9%HD$309.88+0.1%HEI.DE€144.35+1.6%HEN3.DE€79.02+1.5%HFG.DE€3.02-0.5%HIK.L1,662.00 p+1.2%HILS.L3,035.00 p+0.3%HLE.DE€70.60-1.0%HLMA.L3,428.00 p+0.9%HLN.L375.10 p+0.1%HLT$346.04+0.3%HNR1.DE€274.40+0.9%HOC.L517.00 p+1.0%HON$209.98-0.7%HOOD$96.52-2.4%HOT.DE€372.60+1.1%HPE$55.87+1.3%HSBA.L1,428.00 p+0.5%HSX.L1,867.00 p+0.8%HUM$414.98+0.4%HWDN.L788.00 p+1.5%HWM$220.03-0.4%IAG.L414.80 p+0.3%IBM$236.39+1.8%ICE$158.40-2.0%ICG.L1,796.00 p+0.6%ICP$2.84-2.2%IFX.DE€52.39-0.2%IGG.L987.00 p+0.9%IHG.L$170.00+1.9%III.L2,468.00 p+0.9%IMB.L2,879.00 p+1.9%IMI.L2,980.00 p+1.0%INCH.L691.50 p+0.7%INF.L883.60 p+0.1%INPP.L137.60 p0.0%INTC$92.03+2.4%INTU$325.62+0.1%INVP.L604.50 p+0.5%ISRG$433.18+1.5%ITH.L298.20 p+2.3%ITRK.L5,920.00 p0.0%ITV.L66.30 p+2.9%ITW$270.17-0.8%JCI$148.22+1.9%JD.L93.78 p+1.6%JEN.DE€36.64-0.9%JMAT.L2,522.00 p+2.4%JNJ$253.79-0.7%JPM$333.53-1.8%JUN3.DE€22.06+1.8%KBX.DE€99.50+0.4%KEYS$335.86+1.4%KGF.L348.80 p+2.9%KGX.DE€34.09+0.9%KKR$87.00+0.9%KLAC$166.40+0.4%KMI$33.39-2.4%KO$93.42-0.5%KRN.DE€112.60+1.4%LAND.L650.50 p-0.2%LEG.DE€46.76+0.2%LGEN.L298.80 p+1.5%LHA.DE€7.19-0.2%LIN$503.44+1.0%LINK$12.02-0.0%LITE$834.51+1.3%LLOY.L104.85 p-0.9%LLY$1,240.34-1.3%LMP.L179.40 p+0.2%LMT$548.23-0.7%LOW$195.92-0.7%LRCX$272.20+3.1%LSEG.L8,768.00 p+1.0%LTC$59.49+0.7%LXS.DE€13.35+4.1%MA$616.40-0.2%MAR$390.70+0.7%MBG.DE€41.08+2.9%MCD$242.67-0.1%MCK$1,010.43+0.6%MCO$481.26-0.8%MDLZ$63.34-0.9%MDT$92.77-2.1%MET$99.58-1.2%META$705.44-0.5%MKS.L410.60 p-0.4%MMM$162.01-1.7%MNDI.L756.80 p+0.5%MNG.L314.10 p+1.1%MNST$46.80+2.3%MO$74.09-1.4%MPC$473.69-0.9%MPWR$1,253.66+3.5%MRK$143.63-1.6%MRK.DE€144.30+0.7%MRNA$226.89+4.1%MRO.L485.00 p+1.5%MRSH$188.50+0.1%MRVL$237.09+4.1%MS$178.47-1.2%MSFT$533.52+0.8%MSI$458.90-0.9%MTLN.L€49.28+2.2%MTO.L210.40 p+0.1%MTX.DE€352.90-0.0%MU$904.90+3.0%MUV2.DE€547.20+0.4%NDA.DE€153.80-1.3%NDAQ$93.20-0.8%NDX1.DE€39.14+12.3%NEAR$4.78-4.6%NEE$78.17-2.0%NEM$118.01-0.5%NEM.DE€73.55+1.9%NFLX$69.85-1.0%NG.L1,217.50 p+2.0%NKE$37.21+0.2%NOC$510.65-1.8%NOW$145.36+2.4%NSC$323.48-1.1%NUE$260.73+1.7%NVDA$217.09+1.4%NWG.L648.00 p-2.7%NXPI$230.19+0.4%NXT.L15,380.00 p+1.2%O$55.51-1.0%OCDO.L291.20 p-2.9%OKE$92.42-1.0%ONDO$0.4385+1.0%ONT.L200.00 p-4.6%ORCL$129.59+1.1%ORLY$89.07-0.2%OXY$62.72+0.5%P$127.09+2.5%PAF.L118.90 p+0.8%PAH3.DE€25.00+1.7%PANW$346.95+1.4%PCAR$108.42-2.2%PEP$133.57+1.6%PFE$29.44-0.5%PG$157.69-1.0%PGR$219.11+0.3%PH$966.26+0.3%PHP.L91.00 p+1.1%PLD$124.09-1.3%PLTR$194.15+4.4%PM$201.05-2.0%PNC$216.21-0.5%PRU.L906.80 p+0.8%PSA$295.69-0.9%PSH.L3,802.00 p+0.7%PSN.L1,261.50 p-0.2%PSON.L1,374.50 p+1.6%PSX$290.55-0.9%PUM.DE€24.24+0.2%PWR$618.41-2.1%QCOM$173.53+0.8%QIA.DE€41.03-0.2%QLT.L182.20 p+0.5%QNT$193.62+0.9%RAA.DE€616.00+0.8%RCL$281.97+1.5%RDC.DE€74.80+2.0%REGN$782.04-1.1%REL.L2,914.00 p+1.0%RHM.DE€1,090.20+6.3%RIO.L6,816.00 p+0.6%RKT.L5,584.00 p+1.8%RMV.L541.40 p+1.2%ROK$424.47-0.4%ROR.L493.00 p+0.1%ROSE.L311.00 p+1.6%ROST$238.66+0.7%RR.L1,350.60 p-0.9%RRTL.DE€30.70+1.3%RS1.L787.00 p+0.3%RSG$229.03-1.1%RSW.L5,500.00 p+1.5%RTO.L315.90 p+1.4%RTX$192.11-0.9%RWE.DE€59.04+1.9%SAP.DE€199.22-1.0%SAX.DE€38.00-0.4%SBRY.L352.40 p+0.5%SBUX$97.87+0.4%SCHW$89.58-2.6%SCT.L1,700.00 p+0.2%SDF.DE€14.06+0.6%SDLF.L911.00 p+1.7%SGE.L1,122.00 p-1.0%SGRO.L913.20 p-1.1%SHC.L141.10 p+0.4%SHEL.L3,938.00 p+0.8%SHIB$0.0000+0.2%SHL.DE€41.45+1.5%SHW$331.61-1.1%SIE.DE€270.650.0%SLB$49.09-0.8%SMIN.L2,685.00 p+0.5%SMT.L1,545.00 p-3.1%SN.L1,084.50 p-0.3%SNDK$1,371.12+5.5%SNPS$454.58-0.0%SO$89.27-2.1%SOL$104.67+0.6%SPG$202.49-1.4%SPGI$427.83-0.4%SPX.L7,370.00 p+0.5%SRE$81.74-2.0%SRP.L273.40 p+1.2%SSE.L2,574.00 p+1.3%STAN.L2,127.00 p-0.0%STJ.L1,068.00 p+0.7%STM.DE€16.14+3.5%STT$165.43-0.2%STX$660.81+3.4%SVT.L3,220.00 p+0.1%SY1.DE€99.44+0.0%SYK$297.94+1.1%T$23.20-1.0%TATE.L564.00 p0.0%TBCG.L5,080.00 p+0.9%TDG$1,142.45+0.3%TEG.DE€10.50-0.5%TEL$212.33-0.1%TER$335.53+3.2%TFC$46.32-1.6%TGT$153.29-0.6%TJX$147.36+0.0%TKA.DE€14.35+3.0%TLX.DE€124.90+0.4%TMO$679.38-1.5%TMUS$156.09-1.9%TMV.DE€6.99-0.1%TRGP$292.80-0.7%TRV$385.45-1.1%TRX$0.3317-0.2%TSCO.L535.00 p+0.1%TSLA$368.06+3.8%TT$465.04+1.3%TUI1.DE€6.75+1.0%TW.L77.58 p+1.2%TXN$276.15-0.1%UBER$69.96-0.6%ULVR.L4,966.00 p+1.0%UNH$406.88+1.4%UNP$287.01-0.7%UPS$97.46-0.0%URI$1,025.00-0.5%USB$57.85-1.5%UTDI.DE€23.98+0.2%UTG.L446.60 p+0.9%UU.L1,495.00 p+0.8%V$402.92+0.1%VLO$433.31-2.6%VNA.DE€16.83+0.3%VOD.L122.05 p+1.5%VOW3.DE€68.68+2.8%VRT$206.08-0.2%VRTX$501.95+0.4%VST$149.70-1.5%VZ$44.15-1.4%WAB$286.74-0.0%WAF.DE€65.90+1.1%WCH.DE€88.50+0.1%WDC$352.21+6.1%WEIR.L2,682.00 p+2.6%WELL$233.51-0.6%WFC$81.80-2.5%WLD$0.5430+11.0%WM$226.41-0.2%WMB$70.38-1.3%WMT$118.70-0.1%WPP.L412.70 p+3.1%WTB.L2,611.00 p+1.0%XLM$0.1775-0.1%XMR$606.73+1.5%XOM$178.28-0.4%XRP$1.30-0.2%ZAL.DE€25.25+1.5%ZEC$1,138.47+0.8%
Dips
Consumer Cyclical-20.5%🔒Communication Services-15.4%🔒Financial Services-29.2%🔒Industrials-19.5%🔒Industrials-12.4%🔒Real Estate-25.6%🔒Financial Services-19.6%🔒Consumer Cyclical-15.5%🔒Industrials-30.3%🔒Financial Services-21.9%🔒Financial Services-12.7%🔒Financial Services-12.0%🔒Financial Services-21.1%🔒Basic Materials-19.7%🔒Energy-17.1%🔒Consumer Cyclical-16.9%🔒Communication Services-15.8%🔒Financial Services-16.1%🔒Consumer Cyclical-15.7%🔒Basic Materials-15.3%🔒Industrials-9.4%🔒Industrials-32.0%🔒Consumer Cyclical-16.6%🔒Basic Materials-11.0%🔒Consumer Cyclical-17.9%🔒Consumer Cyclical-15.1%🔒Financial Services-9.9%🔒Communication Services-13.8%🔒Industrials-8.2%🔒Consumer Cyclical-6.1%🔒Technology-7.5%🔒
As of 01:45

Vertex Pharmaceuticals

VRTX · NASDAQ · USD · Healthcare

$501.95
+0.4% today

Price

+4.5% since 20/07/2026
1m3m6m
6-week high$535.0020/07/202602/09/202619/10/2026

3 months · High $560.25 (-10.4%) · Low $465.00

What is happening

Vertex Pharmaceuticals has fallen 6% since its 6-week high on 08/09/2026. How it continues – phase and signs – you see with a free account.

Free account · 3 stocks and coins a day

How deep is the dip?

  • from the 6-week high-6.2%

    Highest daily price: $535.00 on 08/09/2026 · reference of the assessment

  • from the 3-month high-10.4%

    Highest daily price in 3 months: $560.25 on 03/09/2026

  • from the 52-week high-10.4%

    Highest price in 52 weeks: $560.25 (Yahoo)

WatchMark as bought

Marking places no order – it only helps you keep track.

Your move on this one?Sign in to record it
Your take on this verdict?Sign in to react

Catalysts

3 h ago
News, last 10 days
no recent news
Next earnings
02/11/2026 · in 13 days
Last report
03/08/2026 -0.3% vs estimate

Trade levels

Free account · 3 stocks and coins a day

Why the engine says so

Free account · 3 stocks and coins a day

History for this stock or coin

Free account · 3 stocks and coins a day

Watch and alert

Free account · 3 stocks and coins a day

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of SCD and TDT; JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1/2 clinical trial; inaxaplin for the treatment of APOL1-mediated kidney disease, which is in single Phase 2 trial; VX-264 for treating Type 1 Diabetes; VX-670 for the treatment of myotonic dystrophy type 1; and VX-407, a small molecule corrector for the treatment of autosomal dominant polycystic kidney disease. In addition, the company also operates as a clinical-stage pharmaceutical company, that focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company sells its products primarily to specialty pharmacy and distributors, wholesalers, retail pharmacies, hospitals, and clinics. Vertex Pharmaceuticals Incorporated has a strategic collaboration with AbCellera Biologics Inc. to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Headquarters:
Boston, United States
52-week range:
$403.16 – $560.25
Website:
vrtx.com

Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search